arrow
E

Edoardo Isnaldi

KU Leuven
H指数:12
被引数:749

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The role of body mass index at diagnosis in patients with inflammatory breast cancer

炎性乳腺癌患者诊断时体重指数的作用

2025-10-120
OAAI
Corrigendum to “Histopathological Insights into Metastatic Breast Cancer Gained From Rapid Autopsies” [Laboratory Investigation 105(2025) 104202]

勘误:“通过快速尸检获取的转移性乳腺癌的病理解剖学见解”[Laboratory Investigation 105(2025) 104202]

2025-08-040
OAAI
Prognostic relation of body mass index on extended aromatase inhibition treatment in postmenopausal patients with estrogen receptor positive breast cancer: A retrospective analysis of the SOLE trial

体重指数对雌激素受体阳性乳腺癌绝经后患者延长芳香酶抑制治疗预后的关系:SOLE试验的回顾性分析

2025-06-010
PRE
Histopathological Insights into Metastatic Breast Cancer Gained From Rapid Autopsies

通过快速尸检获得的转移性乳腺癌的病理学见解

2025-05-290
OAAI
Metastases of primary mixed no-special type and lobular breast cancer display an exclusive lobular histology
BREAST
IF7.9
2024-06-014
OAAI
Rapid autopsies to enhance metastatic research: the UPTIDER post-mortem tissue donation program
2024-04-244
OAAI
Heterogeneity of the hormone receptor-positive breast tumor immune microenvironment according to patient's body mass index

根据患者体重指数的激素受体阳性乳腺肿瘤免疫微环境的异质性

2024-03-220
PRE
Highly populated phylogenetic reconstruction in patients with hormone receptor positive-HER2 non-amplified metastatic breast cancer
2024-03-220
PRE
Comparison of ctDNA detection in seven different types of body liquids from patients with metastatic breast cancer
2024-02-010
PRE
Intra-patient and inter-metastasis heterogeneity of HER2-low status in metastatic breast cancer
2023-07-0122
OA
Comparison of the genomic alterations present in tumor samples from patients with metastatic inflammatory versus non-inflammatory breast cancer reveals AURKA as a potential treatment target

转移性炎性与非炎性乳腺癌患者肿瘤样本中存在的基因组改变的比较揭示了AURKA作为潜在的治疗靶点

BREAST
IF7.9
2023-06-013
OAAI
Breast tumors interfere with endothelial TRAIL at the premetastatic niche to promote cancer cell seeding
2023-03-247
OAAI
ctDNA detection in seven different types of body liquids in patients with metastatic breast cancer
2023-03-010
OA
Current and future diagnostic and treatment strategies for patients with invasive lobular breast cancer (vol 33, pg 769, 2022)
2023-03-010
OA
Inter-lesion heterogeneity of HER2-status in metastatic breast cancer: possible implications for treatment with anti-HER2 antibody-drug conjugates
2023-03-011
OA
Impact of increased adiposity on extended aromatase inhibitor treatment in postmenopausal patients with estrogen receptor positive (ER plus ) breast cancer: a retrospective analysis of the SOLE trial
2023-03-010
PRE
Stromal tumor infiltrating lymphocytes and pathological complete response in patients with inflammatory breast cancer treated with neoadjuvant chemotherapy
2023-03-011
OA
Evaluation of changes in sequencing quality and transcriptomic profiles with increasing post-mortem interval: results from an optimization experiment within the UPTIDER tissue donation program
2023-03-010
OA
Advancing research on metastatic breast cancer: the UPTIDER post-mortem tissue donation program
2023-03-010
OA
Single cell atlas identifies lipid-processing and immunomodulatory endothelial cells in healthy and malignant breast

单细胞图谱识别健康和恶性乳腺中的脂质加工和免疫调节内皮细胞

2022-09-2062
OAAI